Author

Derrick S. Haslem

Intermountain Healthcare

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:variant calling· 2 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:spatial transcriptomics· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Hanlee P. JiiD· 3 shared Lincoln D. NadauldiD· 3 shared Gail Fulde· 2 shared HoJoon LeeiD· 2 shared John BelliD· 2 shared Stephanie GreeriD· 2 shared Tyler BarkeriD· 2 shared Andrew SuiD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenomics

Hanlee P. JiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The single-cell spatial landscape of stage III colorectal cancers

Andrew Su, HoJoon Lee, Minh Tran, Richard Cruz, Anuja Sathe, Xiangqi Bai, Ignacio Alberto Wichmann, Lance T. Pflieger, Bryce Moulton, Tyler Barker, Derrick S. Haslem, David A. Jones, Lincoln D. Nadauld, Quan Hoang Nguyen, Hanlee P. Ji, Terence Duane Rhodes

This study uses spatial single-cell analysis to identify 10 cell phenotypes in stage III colorectal cancers and links specific spatial features to recurrence risk.

npj Precision Oncology · Apr 6, 2025Peer-reviewedCancer Biology

Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer

Li C. Xia, Paul Van Hummelen, Matthew A. Kubit, HoJoon Lee, John Bell, Susan M. Grimes, Christina M. Wood-Bouwens, Stephanie Greer, Tyler Barker, Derrick S. Haslem, James M. Ford, Gail Fulde, Hanlee P. Ji, Lincoln D. Nadauld

The paper identifies TP53 genomic deletions as a poor prognosis marker in Stage III colorectal cancer using a new low-coverage whole-genome sequencing protocol.

Scientific Reports · Mar 19, 2020Peer-reviewedGenomics

Genetic risk of cholangiocarcinoma is linked to the autophagy gene ATG7

Stephanie Greer, Margret Helga Ogmundsdottir, Jiamin Chen, Billy T. Lau, Richard Glenn C. Delacruz, Imelda T. Sandoval, Sigrún Kristjánsdóttir, David A. Jones, Derrick S. Haslem, Robin Romero, Gail Fulde, John Bell, Jon Gunnlaugur Jonasson, Eirı́kur Steingrı́msson, Hanlee P. Ji, Lincoln D. Nadauld

The paper identifies ATG7 as a genetic risk factor for cholangiocarcinoma through germline mutations and population studies, linking autophagy dysfunction to cancer development.

bioRxiv · Nov 22, 2019 · PreprintGenomics